Lynovex Clinical Trial Data Published

PhIIa clinical trial data for lynovex (cysteamine) in Cystic Fibrosis published in clinical drug investigation.

As part of Lynovex’s continued and rapid development for use in acute exacerbations in CF, data from the 2014/15 PhIIa clinical trial on the lung and blood levels of drug achieved in CF patients after taking the gel capsule form of cysteamine have now been published in the peer reviewed journal, Clinical Drug Investigation. See Lynovex Clinical trial data for full access details.